Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to EGFR TKIs in never smokers with stage IV EGFR mutant squamous cell carcinoma of the lung (SQCC)
    Meeting Abstract

    Paik, P. K.; Rekhtman, N.; Riely, G. J.; Miller, V. A.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m(2) for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Lisa, D. M.; Agarwal, N.; Algazy, K. M.; Brockstein, B.; Langer, C. J.; Lim, D.; Mehra, R.; Rajan, S. K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations
    Meeting Abstract

    D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005
    Meeting Abstract

    Crinò, L.; Kim, D.; Riely, G. J.; Janne, P. A.; Blackhall, F. H.; Camidge, D. R.; Hirsh, V.; Mok, T.; Solomon, B. J.; Park, K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Disease flare after tyrosine kinase inhibitor (TKI) discontinuation in patients with EGFR-mutant lung cancer and acquired resistance
    Meeting Abstract

    Chaft, J. E.; Oxnard, G. R.; Miller, V. A.; Kris, M. G.; Sima, C. S.; Riely, G. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Small cell and neuroendocrine tumors of the lung
    Book Section

    Krug, L. M.; Pietanza, M. C.; Kris, M. G.; Rosenzweig, K.; Travis, W. D.
    In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 9th ed (2011)

    Fulltext@MSK | Save
  • Antiemetics: American Society of Clinical Oncology clinical practice guideline update
    Journal Article

    Basch, E.; Hesketh, P. J.; Kris, M. G.; Prestrud, A. A.; Temin, S.; Lyman, G. H.
    Journal of Oncology Practice (2011)

    Fulltext@MSK | Save
  • Creating a new multi-modality treatment paradigm for malignant pleural mesothelioma (MPM) using intensity modulated radiation therapy (IMRT) to the pleura
    Meeting Abstract

    Zauderer, M. G.; Rimner, A.; Rosenzweig, K.; Rusch, V.; Adusumilli, P.; Kass, S.; Krug, L. M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Poly adenosine diphosphate-ribose polymerase inhibitors and heat shock protein 90 inhibitors
    Journal Article

    Riely, G. J.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save